Treatment with PDTC abundantly induced MT-I expression through regulating epigenetic modulation but not an NFκB-dependent pathway in HCC, thereby reducing cancer cell proliferation and tumor growth in a xenograft mouse model [25]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.